Market Closed - Toronto S.E. 03:09:37 2024-04-26 pm EDT 5-day change 1st Jan Change
1.97 CAD -1.50% Intraday chart for BioRem Inc. -4.37% +97.00%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
BioRem Shares Jump 29% as its Fourth-Quarter Profit Triples MT
BioRem Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
BioRem Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
BioRem Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
BioRem Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
BIOREM Inc. Announces $10.6 Million of New Orders for Air Emissions Abatement Projects in North America CI
BioRem Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
BioRem's Q4 Profit Declines, Revenue Grows MT
BioRem Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
BioRem Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
BIOREM Says Several New Orders Drive Order Backlog to Record $44.5 Million MT
BioRem Inc. Announces Several New Orders CI
Biorem Q2 EPS $0.010 Vs $0.007 Year Ago; Revenue, Order Backlog Increase MT
BioRem Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Biorem Says Order Backlog Grows to $40-Million on Strength of $11 Million In New Orders MT
Biorem Brief: Says Order Backlog Grows to $40-million on Strength of $11 Million In New Orders MT
Biorem Inc. Announces $11 Million of New Orders for Air Emission Abatement Projects in North America CI
Biorem Q1 Net Loss $0.01 Per Share; Revenue Rises 28% From Year Ago MT
BIOREM Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Biorem Fourth-Quarter Profit Climbs 38% on Higher Revenue MT
Tranche Update on BIOREM Inc.'s Equity Buyback Plan announced on August 5, 2021. CI
BIOREM Inc. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
BIOREM Announces Several Orders Totalling $9.2 Million MT
BIOREM Inc. Announces Several Orders Totaling $9.2 Million and Order Backlog of $34.6 Million CI
BIOREM Inc.'s Equity Buyback announced on August 5, 2021, has closed with 23,434,121 shares, for CAD 12.32 million. CI
Chart BioRem Inc.
More charts
Biorem Inc. is a Canada-based clean technology company. The Company designs, manufactures and distributes a line of air emissions control systems used to eliminate odors, volatile organic compounds (VOCs) and hazardous air pollutants (HAPs). It operates through one reportable segment, which involves the manufacture and sale of pollution control systems. Its solutions include BASYS and BiofiltAIR biofilter, MYTILUS biotrickling filter, multi-stage SYNERGY system, biogas desulfurization, dry scrubber adsorption systems and cannabis odor control. Its BASYS and BiofiltAIR biofilter systems are suited for odor control applications, especially when removing reduced sulfur compounds or VOCs. It offers biofiltration medias, which include BIOSORBENS, XLD, BIOPAK and BIOROLL & BIOBLOK. The Company's service solutions include system upgrades, preventative maintenance, and replacement and spare parts. Its other services dispersion modeling, permit applications and community outreach programs.
More about the company
  1. Stock Market
  2. Equities
  3. BRM Stock
  4. News BioRem Inc.
  5. BIOREM Announces Several Orders Totalling $9.2 Million